MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
COYA — Coya Therapeutics, Inc. Common Stock
NasdaqCoya Therapeutics, Inc. Common Stock
$4.81
+0.08(+1.69%)
- O
- 4.80
- H
- 4.93
- L
- 4.76
- V
- 88.69K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About COYA
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateDec 29, 2022
Employees8
Stock ExchangeNasdaq
Ticker SymbolCOYA
Key Financial Statistics
| Market Cap | $119.17M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $3.71 - $7.75 |
| 52-Week Avg Volume | 191.6K |
| VWAP | $4.81 |
| Transactions | 1,303 |
| Total Recorded Bars | 943 days |